{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T18:19:28Z","timestamp":1777141168009,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.autrev.2005.10.003","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T08:43:41Z","timestamp":1131007421000},"page":"160-164","source":"Crossref","is-referenced-by-count":35,"title":["Toxic epidermal necrolysis in systemic lupus erythematosus"],"prefix":"10.1016","volume":"5","author":[{"given":"Nathanael S.","family":"Horne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana R.","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose-Marie","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Frieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2005.10.003_bib1","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2005.10.003_bib2","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1001\/archderm.123.9.1166","article-title":"The culprit drugs in 87 cases of toxic epidermal necrolysis","volume":"123","author":"Gillaume","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2005.10.003_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archderm.139.1.39","article-title":"Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States","volume":"139","author":"Trent","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2005.10.003_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1081-1206(10)61112-X","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a review of the literature","volume":"94","author":"Letko","year":"2005","journal-title":"Ann Allergy Asthma Immun"},{"key":"10.1016\/j.autrev.2005.10.003_bib5","series-title":"Cellular and molecular immunology","author":"Abbas","year":"2005"},{"key":"10.1016\/j.autrev.2005.10.003_bib6","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)64284-8","article-title":"Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome are induced by soluble Fas ligand","volume":"162","author":"Abe","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2005.10.003_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archderm.131.5.544","article-title":"Metabolic predisposition to cutanous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants","volume":"131","author":"Wolkenstein","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2005.10.003_bib8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archderm.129.4.466","article-title":"Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement","volume":"129","author":"Correia","year":"1993","journal-title":"Arch Dermatolh"},{"issue":"19","key":"10.1016\/j.autrev.2005.10.003_bib9","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Medical progress: severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"NEJM"},{"issue":"4","key":"10.1016\/j.autrev.2005.10.003_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1067\/mjd.2002.127249","article-title":"Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children","volume":"47","author":"Tristani-Firouzi","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2005.10.003_bib11","series-title":"Rheumatology","first-page":"7.2.1","article-title":"Systemic lupus erythematosus: immunopathology","author":"Edberg","year":"1998"},{"key":"10.1016\/j.autrev.2005.10.003_bib12","series-title":"Rheumatology","first-page":"7.1.1","article-title":"Systemic lupus erythematosus: clinical features","author":"Gladman","year":"1998"},{"issue":"11","key":"10.1016\/j.autrev.2005.10.003_bib13","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/archderm.111.11.1448","article-title":"Discoid lupus erythematosus as part of a larger disease spectrum. Correlation of clinical features with laboratory findings in lupus erythematosus","volume":"111","author":"Prystowsky","year":"1975","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2005.10.003_bib14","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0190-9622(83)70210-0","article-title":"Vesiculobullous systemic lupus erythematosus. Report of two cases and a review of the literature","volume":"9","author":"Camisa","year":"1983","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2005.10.003_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1067\/mjd.2003.107","article-title":"Lupus-associated toxic epidermal necrolysis: a novel manifestation of lupus?","volume":"48","author":"Mandelcorn","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2005.10.003_bib16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archderm.123.9.1171","article-title":"Genetic susceptibility to toxic epidermal necrolysis","volume":"123","author":"Roujeau","year":"1987","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2005.10.003_bib17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0190-9622(84)80317-5","article-title":"Observations on drug-induced toxic epidermal necrolysis in Singapore","volume":"10","author":"Chan","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2005.10.003_bib18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0190-9622(85)80447-3","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in a patient with systemic lupus erythematosus [letter]","volume":"13","author":"Burge","year":"1985","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2005.10.003_bib19","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0190-9622(87)80031-2","article-title":"Lupus erythematosus and toxic epidermal necrolysis [letter]","volume":"16","author":"Bielsa","year":"1987","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.autrev.2005.10.003_bib20","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1177\/106002809302701212","article-title":"Ciprofloxacin-induced toxic epidermal necrolysis","volume":"27","author":"Moshfeghi","year":"1993","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.autrev.2005.10.003_bib21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s15010-003-2128-3","article-title":"Ciprofloxacin-induced toxic epidermal necrolysis in a patient with systemic lupus erythematosus","volume":"31","author":"Jongen-Lavrencic","year":"2003","journal-title":"Infection"},{"issue":"12","key":"10.1016\/j.autrev.2005.10.003_bib22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1191\/0961203304lu2037sa","article-title":"Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus and the spectrum of the Acute Syndrome of Apoptotic Pan-Epidermolysis (ASAP): a case report, concept review and proposal for new classification of lupus erythematosus vesiculobullous skin lesions","volume":"13","author":"Ting","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2005.10.003_bib23","first-page":"113","article-title":"Toxic epidermal necrolysis in a female patient with systemic lupus erythematosus","volume":"11","author":"Lemziakov","year":"1991","journal-title":"Vrach Delo"},{"issue":"1","key":"10.1016\/j.autrev.2005.10.003_bib24","first-page":"1","article-title":"Focal epidermal necrolysis. A variation of lupus erythematosus of a new disease?","volume":"5","author":"Pinol Aguade","year":"1977","journal-title":"Med Cutan Ibero Lat Am"},{"issue":"11","key":"10.1016\/j.autrev.2005.10.003_bib25","first-page":"1077","article-title":"Toxic epidermic necrolysis in acute disseminated lupus erythematosus","volume":"107","author":"Sayag","year":"1980","journal-title":"Ann Dermatol Venereol"},{"issue":"8463","key":"10.1016\/j.autrev.2005.10.003_bib26","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(85)90918-3","article-title":"Adverse drug reaction monitoring: doing it the French way","volume":"2","author":"Moore","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2005.10.003_bib27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/archderm.136.3.323","article-title":"Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?","volume":"136","author":"Garcia-Doval","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2005.10.003_bib28","first-page":"319","article-title":"Complement-related diseases","volume":"23","author":"Frieri","year":"2002","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.autrev.2005.10.003_bib29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.autrev.2005.10.003_bib30","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Advances in immunology: immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.autrev.2005.10.003_bib31","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJM199511303332207","article-title":"Management of acquired bullous skin diseases","volume":"30;333","author":"Fine","year":"1995","journal-title":"N Engl J Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997205001783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997205001783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:41:57Z","timestamp":1554338517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997205001783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S1568997205001783"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2005.10.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}